CrossRef 10. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R,

Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, Emergency Physicians Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Respiratory Society International Sepsis Forum Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society World Federation of Societies of Intensive and Critical Care Medicine: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008,36(1):296–327.PubMedCrossRef 11. Moore LJ, Moore FA: Epidemiology Protein Tyrosine Kinase inhibitor of sepsis in surgical patients. Surg Clin North Am 2012,92(6):1425–1443.PubMedCrossRef 12. Moore LJ, Moore FA, Jones SL, Xu J, Bass BL: Sepsis in general BIX 1294 research buy surgery: a deadly complication. Am

J Surg 2009,198(6):868–874.PubMedCrossRef 13. Vincent JL, Biston P, Devriendt J, Brasseur A, De check details Backer D: Dopamine versus norepinephrine: is one better? Minerva Anestesiol 2009,75(5):333–337.PubMed 14. Hollenberg SM: Vasopressor support in septic shock. Chest 2007,132(5):1678–1687.PubMedCrossRef 15. Kellum J, Decker J: Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001, 29:1526–1531.PubMedCrossRef 16. Hesselvik JF, Brodin B: Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport.

Crit Care Med 1989, 17:179–180.PubMedCrossRef 17. Meadows D, Edwards JD, Wilkins RG, Nightingale P: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988, 16:663–667.PubMedCrossRef Oxaprozin 18. Martin C, Papazian L, Perrin G, Saux P, Gouin F: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993, 103:1826–1831.PubMedCrossRef 19. Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA: Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2010,33(4):375–380.PubMedCrossRef 20. Flancbaum L, Dick M, Dasta J, Sinha R, Choban P: A dose–response study of Phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997, 51:461–465.PubMedCrossRef 21. De Backer D, Creteur J, Silva E, Vincent JL: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003,31(6):1659–1667.PubMedCrossRef 22. Holmes CL, Patel BM, Russell JA, Walley KR: Physiology of vasopressin relevant to management of septic shock. Chest 2001,120(3):989–1002.PubMedCrossRef 23.